Safety Study of LLF580 in Obese Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The purpose of the study is to evaluate the safety and tolerability of multiple doses of LLF580 administered subcutaneously over 3 months in obese subjects. In addition, the study will also determine early efficacy signals in various metabolic diseases associated with elevated triglycerides and/or obesity.
Epistemonikos ID: 7479c882f23323603fbe3d8494bd1751ae83cf70
First added on: May 21, 2024